Authors Mahmood K, Thomas M, Qu C. et al., and Peters U.Citation Gastroenterology. 2023 Oct;165(4):1070-1076.e3.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37453563PMCID PMC10866455
Using DEPendency of association on the number of Top Hits (DEPTH) as a complementary tool to identify novel colorectal cancer susceptibility loci
Authors Lai J, Wong CK, Schmidt D. et al., and Makalic E.Citation Cancer Epidemiol Biomarkers Prev. 2023 Jun 26;EPI-22-1209.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37364297PMCID PMC10529807
A Highly Sensitive Pan-Cancer Test for Microsatellite Instability
Authors Bacher, JW, Edho EB, Strauss EE, et al., et al., and Halberg RB.Citation J Mol Diagn. 2023 Aug 5;25(11):806-826.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37544360PMCID PMC10629437
The association between genetically elevated polyunsaturated fatty acids and risk of cancer
Authors Haycock PC, Borges MC, Burrows K, et al, and Martin RM.Citation EBioMedicine. 2023 May;91:104510.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37086649PMCID PMC10148095
Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses
Authors Dimou N, Kim AE, Flanagan O, et al, and Peters U.Citation Br J Cancer. 2023 Aug;129(3):511-520.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37365285PMCID PMC10403521
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers
Authors Joo JE, Mahmood K, Walker R, et al, and Buchanan DD.Citation Clin Epigenetics. 2023 Jun 3;15(1):95.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37270516PMCID PMC10239107
Identifying metabolic features of colorectal cancer liability using Mendelian randomization
Authors Bull CJ, Hazelwood E, Bell JA, et al, and Vincent EE.Citation medRxiv. 2023 Aug 1;2023.03.10.23287084.PubMedLink https://pubmed.ncbi.nlm.nih.gov/36945480PMCID PMC10029059
Genome-wide interaction analysis of folate for colorectal cancer risk
Authors Bouras E, Kim AE, Lin Y, et al, and Tsilidis KK.Citation Am J Clin Nutr. 2023 Aug 26;S0002-9165(23)66108-8.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37640106PMCID PMC10636229
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
Authors Yarmolinsky J, Bouras E, Constantinescu A, et al, and Tsilidis KK.Citation Diabetologia. 2023 Aug;66(8):1481-1500.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37171501PMCID PMC10317892
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study
Authors Pham TT, Nimptsch K, Papadimitriou N, et al, and Pischon T.Citation J Cancer Res Clin Oncol. 2023 Aug 21.PubMedLink https://pubmed.ncbi.nlm.nih.gov/37599317PMCID PMC10602946